首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Phosphonamidates are the first phosphorus-based zinc binding motif to show inhibition of β-class carbonic anhydrases from bacteria, fungi, and protozoa
【24h】

Phosphonamidates are the first phosphorus-based zinc binding motif to show inhibition of β-class carbonic anhydrases from bacteria, fungi, and protozoa

机译:氨基酰胺是第一种基于磷的锌结合基序,显示来自细菌,真菌和原生动物的β级碳酸酐酶的抑制作用

获取原文
           

摘要

A primary strategy to combat antimicrobial resistance is the identification of novel therapeutic targets and anti-infectives with alternative mechanisms of action. The inhibition of the metalloenzymes carbonic anhydrases (CAs, EC 4.2.1.1) from pathogens (bacteria, fungi, and protozoa) was shown to produce an impairment of the microorganism growth and virulence. As phosphonamidates have been recently validated as human α-CA inhibitors (CAIs) and no phosphorus-based zinc-binding group have been assessed to date against β-class CAs, herein we report an inhibition study with this class of compounds against β-CAs from pathogenic bacteria, fungi, and protozoa. Our data suggest that phosphonamidates are among the CAIs with the best selectivity for β-class over human isozymes, making them interesting leads for the development of new anti-infectives.
机译:用于打击抗微生物抗性的主要策略是鉴定具有替代作用机制的新型治疗靶标和抗感染性。显示抑制金属酶碳酸酐酶(CAS,EC 4.2.1.1)从病原体(细菌,真菌和原生动物)中显示出微生物生长和毒力的损害。作为膦酰胺最近被验证为人α-Ca抑制剂(CAIS),并且没有对β-类CAS的迄今为止没有评估基于磷的锌结合基团,在此报告与对β-CA的这类化合物进行抑制研究来自致病菌,真菌和原生动物。我们的数据表明,膦酰胺是CAI的具有最佳选择性对人类同工酶的β-级选择性,使它们具有开发新的抗感染性的有趣。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号